140 related articles for article (PubMed ID: 15715486)
1. Synthesis and evaluation of S-acyl-2-thioethyl esters of modified nucleoside 5'-monophosphates as inhibitors of hepatitis C virus RNA replication.
Prakash TP; Prhavc M; Eldrup AB; Cook PD; Carroll SS; Olsen DB; Stahlhut MW; Tomassini JE; MacCoss M; Galloway SM; Hilliard C; Bhat B
J Med Chem; 2005 Feb; 48(4):1199-210. PubMed ID: 15715486
[TBL] [Abstract][Full Text] [Related]
2. Prodrugs of Ara-CMP and Ara-AMP with a S-acyl-2-thioethyl (SATE) biolabile phosphate protecting group: synthesis and biological evaluation.
Bazzanini R; Manfredini S; Durini E; Gröschel B; Cinatl J; Balzarini J; De Clercq E; Imbach JL; Périgaud C; Gosselin G
Nucleosides Nucleotides; 1999; 18(4-5):971-2. PubMed ID: 10432722
[TBL] [Abstract][Full Text] [Related]
3. Anti-hepatitis C virus activity of novel beta-d-2'-C-methyl-4'-azido pyrimidine nucleoside phosphoramidate prodrugs.
Rondla R; Coats SJ; McBrayer TR; Grier J; Johns M; Tharnish PM; Whitaker T; Zhou L; Schinazi RF
Antivir Chem Chemother; 2009 Oct; 20(2):99-106. PubMed ID: 19843980
[TBL] [Abstract][Full Text] [Related]
4. Discovery of 4'-azido-2'-deoxy-2'-C-methyl cytidine and prodrugs thereof: a potent inhibitor of Hepatitis C virus replication.
Nilsson M; Kalayanov G; Winqvist A; Pinho P; Sund C; Zhou XX; Wähling H; Belfrage AK; Pelcman M; Agback T; Benckestock K; Wikström K; Boothee M; Lindqvist A; Rydegård C; Jonckers TH; Vandyck K; Raboisson P; Lin TI; Lachau-Durand S; de Kock H; Smith DB; Martin JA; Klumpp K; Simmen K; Vrang L; Terelius Y; Samuelsson B; Rosenquist S; Johansson NG
Bioorg Med Chem Lett; 2012 May; 22(9):3265-8. PubMed ID: 22472694
[TBL] [Abstract][Full Text] [Related]
5. Discovery of Novel Nucleotide Prodrugs with Improved Potency Against HCV Variants Carrying NS5B S282T Mutation.
Zhen L; Dai L; Wen X; Yao L; Jin X; Yang XW; Zhao W; Yu SQ; Yuan H; Wang G; Sun H
J Med Chem; 2017 Jul; 60(14):6077-6088. PubMed ID: 28650160
[TBL] [Abstract][Full Text] [Related]
6. The novel nucleoside analog R1479 (4'-azidocytidine) is a potent inhibitor of NS5B-dependent RNA synthesis and hepatitis C virus replication in cell culture.
Klumpp K; Lévêque V; Le Pogam S; Ma H; Jiang WR; Kang H; Granycome C; Singer M; Laxton C; Hang JQ; Sarma K; Smith DB; Heindl D; Hobbs CJ; Merrett JH; Symons J; Cammack N; Martin JA; Devos R; Nájera I
J Biol Chem; 2006 Feb; 281(7):3793-9. PubMed ID: 16316989
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of hepatitis C virus RNA replication by 2'-modified nucleoside analogs.
Carroll SS; Tomassini JE; Bosserman M; Getty K; Stahlhut MW; Eldrup AB; Bhat B; Hall D; Simcoe AL; LaFemina R; Rutkowski CA; Wolanski B; Yang Z; Migliaccio G; De Francesco R; Kuo LC; MacCoss M; Olsen DB
J Biol Chem; 2003 Apr; 278(14):11979-84. PubMed ID: 12554735
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of 2'-substituted nucleosides on hepatitis C virus replication correlates with metabolic properties in replicon cells.
Tomassini JE; Getty K; Stahlhut MW; Shim S; Bhat B; Eldrup AB; Prakash TP; Carroll SS; Flores O; MacCoss M; McMasters DR; Migliaccio G; Olsen DB
Antimicrob Agents Chemother; 2005 May; 49(5):2050-8. PubMed ID: 15855531
[TBL] [Abstract][Full Text] [Related]
9. PSI-7851, a pronucleotide of beta-D-2'-deoxy-2'-fluoro-2'-C-methyluridine monophosphate, is a potent and pan-genotype inhibitor of hepatitis C virus replication.
Lam AM; Murakami E; Espiritu C; Steuer HM; Niu C; Keilman M; Bao H; Zennou V; Bourne N; Julander JG; Morrey JD; Smee DF; Frick DN; Heck JA; Wang P; Nagarathnam D; Ross BS; Sofia MJ; Otto MJ; Furman PA
Antimicrob Agents Chemother; 2010 Aug; 54(8):3187-96. PubMed ID: 20516278
[TBL] [Abstract][Full Text] [Related]
10. Antiviral efficacy upon administration of a HepDirect prodrug of 2'-C-methylcytidine to hepatitis C virus-infected chimpanzees.
Carroll SS; Koeplinger K; Vavrek M; Zhang NR; Handt L; MacCoss M; Olsen DB; Reddy KR; Sun Z; van Poelje PD; Fujitaki JM; Boyer SH; Linemeyer DL; Hecker SJ; Erion MD
Antimicrob Agents Chemother; 2011 Aug; 55(8):3854-60. PubMed ID: 21628542
[TBL] [Abstract][Full Text] [Related]
11. Nucleoside analog inhibitors of hepatitis C virus replication.
Carroll SS; Olsen DB
Infect Disord Drug Targets; 2006 Mar; 6(1):17-29. PubMed ID: 16787301
[TBL] [Abstract][Full Text] [Related]
12. 2'-Deoxy-2'-spirocyclopropylcytidine revisited: a new and selective inhibitor of the hepatitis C virus NS5B polymerase.
Jonckers TH; Lin TI; Buyck C; Lachau-Durand S; Vandyck K; Van Hoof S; Vandekerckhove LA; Hu L; Berke JM; Vijgen L; Dillen LL; Cummings MD; de Kock H; Nilsson M; Sund C; Rydegård C; Samuelsson B; Rosenquist A; Fanning G; Van Emelen K; Simmen K; Raboisson P
J Med Chem; 2010 Nov; 53(22):8150-60. PubMed ID: 21033671
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of novel phosphoramidate prodrugs of 2'-methyl cytidine as inhibitors of hepatitis C virus NS5B polymerase.
Donghi M; Attenni B; Gardelli C; Marco AD; Fiore F; Giuliano C; Laufer R; Leone JF; Pucci V; Rowley M; Narjes F
Bioorg Med Chem Lett; 2009 Mar; 19(5):1392-5. PubMed ID: 19181520
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and antiviral activity of adenosine 5'-phosphonate analogues as chain terminators against hepatitis C virus.
Koh YH; Shim JH; Wu JZ; Zhong W; Hong Z; Girardet JL
J Med Chem; 2005 Apr; 48(8):2867-75. PubMed ID: 15828825
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological activity of a gemcitabine phosphoramidate prodrug.
Wu W; Sigmond J; Peters GJ; Borch RF
J Med Chem; 2007 Jul; 50(15):3743-6. PubMed ID: 17602464
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of hepatitis C virus replication by GS-6620, a potent C-nucleoside monophosphate prodrug.
Feng JY; Cheng G; Perry J; Barauskas O; Xu Y; Fenaux M; Eng S; Tirunagari N; Peng B; Yu M; Tian Y; Lee YJ; Stepan G; Lagpacan LL; Jin D; Hung M; Ku KS; Han B; Kitrinos K; Perron M; Birkus G; Wong KA; Zhong W; Kim CU; Carey A; Cho A; Ray AS
Antimicrob Agents Chemother; 2014; 58(4):1930-42. PubMed ID: 24419349
[TBL] [Abstract][Full Text] [Related]
17. Discovery of β-d-2'-deoxy-2'-dichlorouridine nucleotide prodrugs as potent inhibitors of hepatitis C virus replication.
Pinho P; Kalayanov G; Westerlind H; Rosenquist Å; Wähling H; Sund C; Almeida M; Ayesa S; Tejbrant J; Targett-Adams P; Eneroth A; Lindqvist A
Bioorg Med Chem Lett; 2017 Aug; 27(15):3468-3471. PubMed ID: 28622881
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antiviral properties of novel tetracyclic nucleoside inhibitors of hepatitis C NS5B polymerase.
Di Francesco ME; Avolio S; Dessole G; Koch U; Pompei M; Pucci V; Rowley M; Summa V
Nucleosides Nucleotides Nucleic Acids; 2012; 31(8):592-607. PubMed ID: 22908950
[TBL] [Abstract][Full Text] [Related]
19. Cyclic phosphoramidates as prodrugs of 2'-C-methylcytidine.
Meppen M; Pacini B; Bazzo R; Koch U; Leone JF; Koeplinger KA; Rowley M; Altamura S; Di Marco A; Fiore F; Giuliano C; Gonzalez-Paz O; Laufer R; Pucci V; Narjes F; Gardelli C
Eur J Med Chem; 2009 Sep; 44(9):3765-70. PubMed ID: 19493593
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of 9-(2-beta-C-methyl-beta-d-ribofuranosyl)-6-substituted purine derivatives as inhibitors of HCV RNA replication.
Ding Y; Girardet JL; Hong Z; Lai VC; An H; Koh YH; Shaw SZ; Zhong W
Bioorg Med Chem Lett; 2005 Feb; 15(3):709-13. PubMed ID: 15664842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
